ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1844

$1.12M Total Retail Price of All Prescriptions

Rank: 31 out of 1844

644 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 644 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 644 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 15,901 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 1,052 982 1 1
FUROSEMIDE 823 755 2 7
SIMVASTATIN 718 624 3 3
CARVEDILOL 489 472 4 22
HYDROCODONE-ACETAMINOPHEN 443 371 S3 5 2
POLYETHYLENE GLYCOL 3350 423 367 6 39
OMEPRAZOLE 415 362 7 5
WARFARIN SODIUM 394 370 8 13
METFORMIN HCL 376 337 9 8
AMLODIPINE BESYLATE 371 355 10 6
LISINOPRIL 333 283 11 4
NYSTATIN 293 266 12 85
NAMENDA 292 292 13 33
CYMBALTA 286 209 14 36
GABAPENTIN 269 236 15 15
TRAMADOL HCL 244 214 16 18
METOPROLOL TARTRATE 217 205 17 11
DONEPEZIL HCL 194 191 18 26
RISPERIDONE 167 142 19 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 167 143 19 73
NOVOLOG MIX 70-30 162 138 21 266
ATENOLOL 160 145 22 17
ALENDRONATE SODIUM 157 157 23 25
LANTUS 156 127 24 42
ESCITALOPRAM OXALATE 141 125 25 52
METOPROLOL SUCCINATE 139 108 26 14
KLOR-CON M20 136 131 27 54
SERTRALINE HCL 135 109 28 21
CEPHALEXIN 131 113 29 56
ATORVASTATIN CALCIUM 130 111 30 12
NEXIUM 129 112 31 31
CELEBREX 126 117 32 91
SPIRONOLACTONE 125 116 33 60
FENTANYL 125 125 S2 33 66
CITALOPRAM HBR 124 122 35 19
DIOVAN 123 116 36 58
PANTOPRAZOLE SODIUM 122 103 37 32
CIPROFLOXACIN HCL 118 108 38 62
ALLOPURINOL 116 101 39 29
POTASSIUM CHLORIDE 116 106 39 16
NITROGLYCERIN PATCH 114 111 41 173
NITROFURANTOIN MONO-MACRO 110 106 42 151
HYDROCHLOROTHIAZIDE 109 103 43 9
NOVOLOG MIX 70-30 FLEXPEN 96 96 44 319
SYNTHROID 91 77 45 55
AZITHROMYCIN 90 74 46 37
KLOR-CON M10 87 78 47 149
ROPINIROLE HCL 84 60 48 76
PAROXETINE HCL 84 58 48 68
CRESTOR 84 79 48 30
LOSARTAN-HYDROCHLOROTHIAZIDE 81 75 51 47
CLOPIDOGREL 80 73 52 34
DIVALPROEX SODIUM 75 74 53 74
BENAZEPRIL HCL 73 65 54 75
ZOLPIDEM TARTRATE 72 72 55 23
LEVEMIR FLEXPEN 70 70 56 166
PREDNISONE 69 61 57 40
LANTUS SOLOSTAR 69 64 57 97
PLAVIX 69 63 57 61
OXYCODONE-ACETAMINOPHEN 69 64 S2 57 94
MIRTAZAPINE 67 67 61 49
TAMSULOSIN HCL 67 67 61 27
AMOXICILLIN 66 64 63 101
EXELON 66 66 63 112
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 64 65 20
TORSEMIDE 65 64 65 118
SINGULAIR 63 57 67 102
ENALAPRIL MALEATE 59 58 68 69
PHENYTOIN SODIUM EXTENDED 57 57 69 147
LOSARTAN POTASSIUM 56 56 70 24
GEMFIBROZIL 56 34 70 108
MELOXICAM 56 45 70 28
AMLODIPINE BESYLATE-BENAZEPRIL 55 50 73 80
DIGOXIN 53 41 74 67
CEFTRIAXONE 53 53 74 213
ADVAIR DISKUS 51 45 76 51
PRAVASTATIN SODIUM 50 50 77 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.